Squarepoint Ops LLC Lowers Position in Relx Plc (NYSE:RELX)

Squarepoint Ops LLC cut its position in shares of Relx Plc (NYSE:RELX - Free Report) by 72.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,697 shares of the technology company's stock after selling 20,010 shares during the quarter. Squarepoint Ops LLC's holdings in Relx were worth $350,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of RELX. CENTRAL TRUST Co increased its position in shares of Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after purchasing an additional 529 shares during the last quarter. Calamos Advisors LLC bought a new position in shares of Relx during the 4th quarter valued at about $561,000. Money Concepts Capital Corp bought a new position in shares of Relx during the 4th quarter valued at about $210,000. Choreo LLC increased its position in shares of Relx by 3.6% during the 4th quarter. Choreo LLC now owns 20,106 shares of the technology company's stock valued at $913,000 after purchasing an additional 702 shares during the last quarter. Finally, Bleakley Financial Group LLC increased its position in shares of Relx by 12.4% during the 4th quarter. Bleakley Financial Group LLC now owns 13,940 shares of the technology company's stock valued at $633,000 after purchasing an additional 1,542 shares during the last quarter. 15.02% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on RELX. Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. The Goldman Sachs Group initiated coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating on the stock. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. Finally, Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Buy".

Relx Price Performance

Shares of Relx stock opened at $53.75 on Friday. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The business's 50 day simple moving average is $52.60 and its two-hundred day simple moving average is $49.66. The stock has a market capitalization of $99.23 billion, a P/E ratio of 28.90, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86. Relx Plc has a one year low of $43.45 and a one year high of $56.33.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.